Frontlight ResearchEarly access
Endometrial cancer trials in United States
200 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleStudy of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
- Where
- Allentown, Basking Ridge, Commack, Harrison, Hartford, Miami, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 212
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04165772 - No phaseTaking peoplecfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Where
- Austin, Charleston, Cleveland, Corbin, Duarte, Elizabethtown, Florence, Gainesville, Lexington, Memphis, Miami, Minneapolis, Nashville, New Albany, Paducah, Portland, Rochester
- Age
- 40 years and over
- People
- 7,000
- Run by
- Adela, Inc
See details and how to joinNCT05366881 - Phase 1/2Taking peopleRinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Where
- Abilene, Augusta, Austin, Boston, Camden, Columbus, Dallas, Detroit, Doylestown, Eugene, Everett, Fairfax, Fort Myers, Fort Worth, Grand Rapids, Los Angeles, Maplewood, Nashville, Norfolk, Oklahoma City, Phoenix, Pittsburgh, Portland, Providence, Rockville, San Diego, Santa Barbara, Santa Rosa, St. Petersburg, Tucson, Tyler, West Palm Beach, West Valley City, Westwood, Woodland
- Age
- 18 years and over
- People
- 952 worldwide
- Run by
- Genmab
See details and how to joinNCT05579366 - Phase 1Taking peopleA Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Where
- Atlanta, Columbus, Falls Church, Grand Rapids, Houston, La Jolla, Mineola, New York, Scottsdale, West Valley City
- Age
- 18 years and over
- People
- 575 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06400472 · EU 2024-511238-11-00 - Phase 2Taking peopleA Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
- Where
- Amarillo, Chicago Ridge, Dallas, Detroit, Fort Myers, Horsham, Houston, Knoxville, Lake Success, Littleton, Nashville, New York, Orlando, Prescott, Roanoke, San Antonio, St. Petersburg, West Palm Beach, Westwood
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT06695845 · EU 2024-516551-41-00 - Phase 2Taking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Birmingham, Boston, Cleveland, Detroit, Duarte, Farmington Hills, Fort Myers, Houston, Madison, Nashville, Seattle
- Age
- 18 years and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - No phaseTaking peopleDistance-Based Exercise to Preserve Function and Prevent Disability
- Where
- Boston, Butler, Cranberry Township, Dublin, Fremont, Fresno, Indiana, Kernersville, Mechanicsville, Midlothian, Modesto, Mount Airy, New Castle, Oakland, Pittsburgh, Richmond, Sacramento, San Francisco, San Jose, San Rafael, Santa Clara, Santa Rosa, Seneca, Vallejo, Walnut Creek, Winston-Salem
- Age
- 18 years and over
- People
- 104
- Run by
- Alliance for Clinical Trials in Oncology
See details and how to joinNCT07059884 - Phase 1Taking peoplePhase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
- Where
- Canton, Charlotte, Dallas, Detroit, Durham, Fairfax, St Louis, West Valley City
- Age
- 18 years and over
- People
- 130 worldwide
- Run by
- Sairopa B.V.
See details and how to joinNCT05856981 - No phaseTaking peopleMolecular and ctDNA Characterization of High-Risk Endometrial Cancer
- Where
- Rochester
- Age
- 18 years and over
- People
- 100
- Run by
- Mayo Clinic
See details and how to joinNCT07062016 - Phase 3Taking peopleStudy to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
- Where
- Arlington, Atlanta, Austin, Baltimore, Baton Rouge, Bedford, Charlotte, Charlottesville, Cincinnati, Concord, Coon Rapids, Dallas, Danbury, Decatur, Durham, Edina, Eugene, Evanston, Fort Worth, Gastonia, Grand Rapids, Happy Valley, Harlingen, Hartford, Irvine, Maple Grove, Maplewood, McAllen, Minneapolis, Mobile, Morristown, New Orleans, New York, Norwalk, Phoenix, Portland, San Antonio, San Francisco, Sarasota, Shreveport, St Louis, St. Petersburg, Summit, Tampa, Teaneck, Tigard, Vancouver, Waco, Washington D.C., Weslaco, Westminster, Winston-Salem, Woodbury, Worcester
- Age
- 18 years and over
- People
- 660 worldwide
- Run by
- Genmab
See details and how to joinNCT07166094 - Phase 3Taking peopleA Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
- Where
- Birmingham, Charlottesville, Omaha, Sugar Land
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07286331 · EU 2025-523362-25-00 - Phase 1Taking peopleStudy of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
- Where
- Fairfax, Houston, Los Angeles, Pittsburgh, San Antonio
- Age
- 18 years and over
- People
- 63
- Run by
- Regor Pharmaceuticals Inc.
See details and how to joinNCT07524322 - Phase 1/2Taking peopleCR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
- Where
- Austin, Dallas, Fairfax
- Age
- 18 years and over
- People
- 219
- Run by
- Crescent Biopharma, Inc.
See details and how to joinNCT07909031 · EU 2026-527289-54-00 - Phase 1/2Taking peopleEIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Where
- Doral, Fort Worth, Hialeah, Houston, Lake Success, Los Angeles, Morristown, New York, Plantation, Tamarac
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT07262619 · EU 2026-525248-13-00 - Phase 3Taking peopleSymbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer
- Where
- Abilene, Albany, Amarillo, Austin, Centerville, Chesapeake, Coon Rapids, Edina, El Paso, Happy Valley, Harlingen, Hudson, Irving, Jupiter, Maple Grove, Maplewood, McAllen, Midland, Nashville, Newport News, Norfolk, Odessa, Orlando, Portland, Reno, Suffolk, Tigard, Vancouver, Waco, Weslaco, White Plains, Wichita Falls, Williamsburg, Woodbury
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Pfizer
See details and how to joinNCT07578649 · EU 2026-525584-40-00 - Phase 1Taking peopleA Phase 1 Study of LNCB74 in Advanced Solid Tumors
- Where
- Boston, Buffalo, Cleveland, Edgewood, Falls Church, Hackensack, Houston, Nashville, Newport Beach, New York, Philadelphia, Pittsburgh, Salt Lake City, San Antonio, St Louis
- Age
- 18 years and over
- People
- 145
- Run by
- LigaChem Biosciences, Inc.
See details and how to joinNCT06774963 - No phaseTaking peopleAvera Cancer Sequencing and Analytics Protocol (ASAP)
- Where
- Aberdeen, Marshall, Mitchell, Pierre, Sioux Falls, Yankton
- Age
- 18 years and over
- People
- 25,000
- Run by
- Avera McKennan Hospital & University Health Center
See details and how to joinNCT05142033 - Phase 1Taking peopleA Study of MGC026 in Participants With Advanced Solid Tumors
- Where
- Grand Rapids, Houston, Lake Success, Los Angeles, Portland, West Valley City
- Age
- 18 years and over
- People
- 394 worldwide
- Run by
- MacroGenics
See details and how to joinNCT06242470 - Phase 1/2Taking peopleA Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Where
- Austin, Boston, Cleveland, Duarte, Fairfax, Houston, Huntersville, Irvine, Milwaukee, Nashville, Omaha, Orlando, Rochester, San Antonio, St Louis, West Valley City, Zion
- Age
- 18 years and over
- People
- 248 worldwide
- Run by
- Terremoto Biosciences Inc.
See details and how to joinNCT07109726 - Phase 3Taking peopleA Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant Setting
- Where
- Bedford, Cincinnati, Coon Rapids, Fort Lauderdale, Fort Wayne, Miami, Miami Beach, Orlando, Pinehurst, Pittsburgh, San Antonio, Shreveport, Sioux Falls
- Age
- 18 years and over
- People
- 710 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT07022483 · EU 2024-519444-33-00 - Phase 2Taking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Baltimore, Buffalo, Chicago, Duarte, Houston, Kissimmee, Nashville, New Haven, New York, Rockville, Saint Louis Park, Saint Paul, Seattle, St Louis
- Age
- 18 years and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Amarillo, Chattanooga, Dallas, Fairfax, Germantown, Los Angeles, Minneapolis, Nashville, New York, Pearland, Salt Lake City, Skokie, Wenatchee, Westbury, White Plains, Whittier
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - Phase 1Taking peopleA Phase 1 Study of the Safety and Tolerability of CTX-10726
- Where
- Greenville, Jacksonville, Lake Success, Nashville, Omaha, Phoenix, Pittsburgh, Rochester
- Age
- 18 years and over
- People
- 70
- Run by
- Compass Therapeutics
See details and how to joinNCT07419841 - Phase 1Taking peoplePhase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
- Where
- Boston, Fairfax, Irving, Lubbock, Oklahoma City, Orlando
- Age
- 18 years and over
- People
- 285
- Run by
- Sutro Biopharma, Inc.
See details and how to joinNCT07807345 - Phase 1/2Taking peopleA Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Where
- Austin, Baton Rouge, Birmingham, Boston, Chattanooga, Cincinnati, Columbia, Dallas, Denver, East Syracuse, Fairfax, Flower Mound, Fort Myers, Hinsdale, Houston, Indianapolis, Jacksonville, Lake Success, Little Rock, Los Angeles, Maple Grove, Maumee, Memphis, Nashville, New York, Oklahoma City, Orlando, Philadelphia, Portland, Rochester, Salt Lake City, San Antonio, Santa Barbara, Santa Rosa, Sarasota, Scottsdale, Seattle, St Louis, Washington D.C., West Palm Beach
- Age
- 18 years and over
- People
- 542 worldwide
- Run by
- Artios Pharma Ltd
See details and how to joinNCT04657068